NORTHBROOK, Ill., Feb. 17, 2017 /PRNewswire/ — Intelligent Medical Objects, Inc. (IMO), a market leader in medical terminology solutions for electronic health record (EHR) systems, today announced ...

CHICAGO--(BUSINESS WIRE)--Intelligent Medical Objects (IMO), a healthcare data enablement company and market leader in clinical terminology services, will be at the Healthcare Information and ...

NORTHBROOK, Ill.--(BUSINESS WIRE)--Intelligent Medical Objects, Inc. (IMO), developer of the most-widely used and physician-preferred terminology service for electronic health records (EHR) systems, ...

Intelligent Medical Objects, Inc. (IMO), developers of the most-widely used and physician-preferred terminology service for electronic health records (EHR) systems, announced that many of the nation’s ...

Intelligent Medical Objects is moving its corporate headquarters, but unlike many other suburban companies in recent year, it’s not heading Downtown. The company, which specializes in healthcare ...

NORTHBROOK, Ill.--(BUSINESS WIRE)-- Intelligent Medical Objects (IMO ®), the leading provider of medical vocabulary services, announces today the availability of its IMO® Problem (IT) and IMO® ...

Chicago, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Intelligent Medical Objects (IMO) launched IMO Precision Normalize, a product that powers more accurate insights with a precise normalization engine that ...

Intelligent Medical Objects, a Rosemont medical data firm that took a $1.5 billion private-equity deal last year, is buying a Texas-based artificial intelligence startup, a move it says will help it ...

Intelligent Medical Objects, a Rosemont, IL-based medical data company, has sold a majority stake to Boston-based private-equity firm Thomas H. Lee Partners in a deal worth more than $1.5 billion. The ...

Thomas H. Lee Partners has agreed to acquire a majority stake in Intelligent Medical Objects, a healthcare data enablement company, from Warburg Pincus. No financial terms were disclosed. Evercore ...

Intelligent Medical Objects, a Rosemont-based medical data company, has sold a majority stake to Boston-based private-equity firm Thomas H. Lee Partners in a deal worth more than $1.5 billion. The ...